Abstract
Introduction
Th e Mini-Mental State Examination (MMSE) is the most commonly used screening test for the assessment of cognitive functioning [1] . Apart from bedside quantification of cognitive impairment, it is of great help in estimating the patients' cognitive change over time and also in monitoring therapeutic response in clinical trials [2] . During the years, the test was found to be relatively sensitive in diagnosing cases of overt dementia; however, its specificity decreases significantly when cognitively healthy individuals and patients with mild cognitive impairment (MCI) should be discriminated. Apart from evident advantages of the MMSE test (e.g. short training required, quick and easy administration, good accessibility), there are also some disadvantages: (1) dependence on demographic variables such as age [3, 4] and education [4] [5] [6] where younger and highly educated persons score more, therefore, necessitating adjustment of the scores to these variables [7, 8] ; (2) the effect of cultural differences, lifestyle, head trauma, and concomitant depression on total scores [9] ; (3) neglecting important domains of cognitive functioning (e.g. executive function) Boban/Malojčić/Mimica/Vuković/Zrilić/ Hof/Šimić that may be impaired early in dementia types other than Alzheimer's disease (AD). The MMSE was introduced in Croatia as a screening protocol for dementia shortly after its publication in 1975 [1] . Despite its widespread use in screening for cognitive impairment, there was no study so far with the aim of standardization and validation of MMSE in Croatian population; therefore, detailed guidelines for administration and interpretation of the test are missing. The aim of this study was to obtain standardization of the MMSE in an ageing Croatian population with the emphasis on the effect of age, gender, and education on MMSE score and cutoff points as well as in different clinical settings (cognitively healthy individuals ≥45 years vs. MCI and demented patients ≥45 years, cognitively healthy individuals ≥45 years vs. demented patients ≥45 years, cognitively healthy individuals ≥65 years vs. demented patients ≥65 years, cognitively healthy individuals ≥65 years vs. AD patients ≥65 years). Finally, we interpreted our results in the context of previously published studies.
Subjects and Methods

Subjects
Subjects were recruited from general practitioners' offices as well as Dementia Outpatient Clinic, Department of Cognitive Neurology, University Hospital Centre Zagreb from April 2009 to December 2011. Native Croatian speakers of 45 years of age or more were included in the study. Exclusion criteria were history of psychiatric illness (e.g. delirium, depression, and psychosis), history of head trauma, chronic alcohol intake, neurological illnesses with possible cognitive deficits (e.g. tumors and infections of the central nervous system), physical disorder or general medical condition affecting the CNS (e.g. hypothyroidism, multisystemic diseases).
Methods
All eligible individuals underwent the MMSE test. The original English version of the MMSE test from 1975 [1] was translated into Croatian by two authors (M.B. and B.M.) with minor changes made based on different translations of verbal instructions. The original style of the MMSE was closely followed with 11 questions and a maximum total score of 30. We used the word TORBA ('bag') for the backwards spelling in the question that estimates attention. Informed consent was obtained before administration of the tests from all subjects participating in the study or their legally assigned caregivers.
All subjects suspected of having cognitive impairment were referred to the Dementia Outpatient Clinic for additional routine evaluation: neurological examination, detailed neurocognitive and neuropsychological evaluation, blood test analysis including complete blood count, electrolytes, thyroid function tests, vitamin B 12 and folic acid levels, ECG and neuroimaging (brain MRI). The imaging studies were carried out on a 1.5-or 3-tesla scanner.
Subjects included in the study were finally divided into two groups: (1) cognitively healthy individuals (without subjective and objective cognitive deficits; recruited from general practitioners' offices, or family members and caregivers of patients), and (2) patients with cognitive impairment (MCI or overt dementia). The diagnoses were established by a team of experienced neurologists and psychiatrists according to the currently recognized clinical criteria for different types of dementia. The diagnosis of 'probable' AD was made according to the criteria of the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorder Association (NINCDS-ADRDA) [10] . Among patients who fulfilled the criteria by Román et al. [11] for vascular dementia, we included only those with subcortical vascular dementia with specific MRI changes (T 2 -weighted subcortical vascular changes without finding of cortical lesions). These patients were included in the group of subcortical vascular cognitive impairment (VCI). The diagnosis of frontotemporal lobar degeneration (FTLD) was made according to the criteria by Neary et al. [12] . The diagnosis of diffuse Lewy body disease (DLBD) was made according to the clinical criteria of the consortium on DLBD [13] . The diagnosis of Parkinson's disease dementia (PDD) was made according to the clinical diagnostic criteria for PDD [14] . The diagnosis of MCI was made according to Petersen's criteria and the criteria of the International Working Group on Mild Cognitive Impairment [15, 16] . Final diagnoses were based on additional results of diagnostic workup and a prolonged follow-up period of up to 12 months. The study was approved by the ethics committee of the University Hospital Center Zagreb. All patients were naive to specific therapy for dementia (e.g. acetylcholinesterase inhibitors and memantine) at the time of inclusion to the study. To quantify severity of dementia, we used the clinical dementia rating scale classifying patients into very mild (MCI), mild, moderate, or severe stages of dementia [17] .
Statistical Analysis
Subjects were divided according to the cognitive status (with or without cognitive impairment or dementia), type and severity of dementia as well as age, gender and education. Subjects with MCI were divided according to the primary cognitive deficit: memory (amnestic type of MCI) or other (nonamnestic type of MCI). Data are presented as mean ± standard deviation and median with range. Sensitivities, specificities, positive predictive values (PPVs), and negative predictive values (NPVs) were calculated at different cutoff points (23/24, 24/25, 25/26, 26/27) between subjects without cognitive impairment and different subsets of cognitively impaired patients (e.g. MCI plus demented patients ≥45 years, demented patients ≥45 years, demented patients ≥65 years, AD patients ≥65 years). The final cutoff points on the MMSE were derived from the receiver operating characteristic curve analysis when the sum of sensitivity and specificity was maximized for each subset of patients. Correlations between MMSE scores and severity of dementia as well as other demographic data were assessed by calculating Spearman's rank correlation coefficients Mini-Mental State Examination in Elderly Croatian Population (r). Statistical analysis was performed using SPSS v.11.0.1; p values lower than 0.05 were considered statistically significant.
Results
Of the 344 participants recruited in the study, 217 subjects had no cognitive impairment and 127 patients had MCI or dementia. In the dementia group, there were 53 patients with AD, 41 with VCI, 14 with FTLD, 7 with DLBD, 5 with PDD, 29 with amnestic type of MCI, 16 with nonamnestic type of MCI, and 7 patients with other types of dementia (3 with posterior cortical atrophy, 2 with corticobasal degeneration, and 2 with normal pressure hydrocephalus). Except for significantly younger ages of subjects without cognitive impairment as well as of patients with FTLD or MCI, there were no other statistically significant differences in age, education and gender among groups. Stratification and demographic data of participants are shown in table 1. The mean MMSE score of subjects without cognitive impairment was 27.9 ± 2.1 points (median 28.0, with a range of 6.0), whereas MMSE scores of MCI, mild, moderate and severe dementia patients were 26.9 ± 2.3, 23.9 ± 2.5, 18.3 ± 2.7, and 10.0 ± 3.2 points, respectively. Medians with interquartile ranges (25th-75th percentile) of MMSE scores are graphically presented in figure 1 . Additionally, mean values and SD as well as medians with ranges of MMSE scores are presented in table 1. Mean MMSE scores for subjects ≥65 years old were as follows: 27.1 ± 2.7 in subjects without cognitive impairment, 24.0 ± 2.5 in a group of mildly demented patients, 17.6 ± 2.9 in a group of moderately demented patients, and 9.7 ± 2.8 in a group of severely demented patients. There was no statistically significant difference in education, gender, or age among groups. Additionally, no statistical difference was found in MMSE scores between female and male subjects without cognitive impairment (28.03 ± 2.3 for women, 27.8 ± 1.7 for men). Distribution of MMSE scores in subjects aged ≥65 years stratified by the presence of cognitive impairment/ dementia and severity of dementia (mild, moderate, severe) is shown as medians and interquartile ranges (25th-75th percentile) in figure 2. Medians with interquartile ranges of MMSE scores of cognitively healthy individuals and AD patients (stratified by severity of dementia) ≥65 years of age are graphically presented in figure 3 . Table 2 presents sensitivities, specificities, PPVs, and NPVs for 4 different settings (cognitively healthy indi- There was no statistically significant correlation between MMSE score and age or level of education in a cognitively healthy group of subjects. A significantly negative correlation between MMSE score and age and MMSE score and disease stage was found in a joint group of cognitively impaired patients (MCI patients and patients with overt dementia). In two other groups (patients with overt dementia and AD patients), as expected there was a significantly negative correlation between MMSE score and stage of the disease. A positive correlation between MMSE score and level of education was found only in a group of patients with overt dementia.
Discussion
The aim of this study was to standardize the MMSE test for the elderly Croatian population with the main focus on finding cutoff points for different clinical settings. According to the first study by Folstein et al. [1] in 1975, the cutoff point for differentiation between demented patients and nondemented individuals was 23/24; however, this result was obviously biased toward the lower MMSE score due to inclusion of solely demented psychiatric in-patients (patients in severe stages of the disease). Later results had shown that the MMSE was less accurate in distinguishing cognitively healthy individuals and patients with dementia in the community populations, especially if MCI patients were included. In our study, at the cutoff point of 23/24 (proposed by Folstein) the sensitivity was 75.51% and specificity was 100% with a PPV of 100% for differentiation of cognitively healthy individuals and patients with overt dementia. These results are in concordance with the previously published articles with sensitivity ranging mostly between 76 and 87% and specificities around 90-95% [18] [19] [20] [21] [22] ; however, lower sensitivities were also reported (around 50-65%) [23, 24] .
By extending the group of overt dementia patients with MCI patients, the optimal cutoff point in our study raised to 26/27 with a sensitivity of 73.47% and a specificity of 95.10%. The same cutoff point was suggested in the study published by O'Bryant et al. [25] with roughly similar sensitivity and specificity (69 and 91%, respectively) and some other publications (the latest MMSE guidelines reported a sensitivity of 83% and specificity of 66%) [22, 26, 27] . Additionally, in our study the optimal cutoff point for discrimination between cognitively healthy individuals and patients with overt dementia was 26/27 with sensitivity of 93.88% and specificity of 95.10%. The high cutoff points found in our study might be explained by more frequent recruitment of patients in the initial stages of dementia as well as higher percentage of highly educated persons than in the general population. However, the cutoff point significantly decreased to 24/25 with inclusion of patients/cognitively healthy individuals aged ≥65 years old with a sensitivity of 87.06% and specificity of 94.44%. The limitation of the MMSE test is that it neglects certain domains of cognitive functioning (e.g. executive function) that are damaged in early stages of dementia types other than AD meaning that some patients may achieve a very high MMSE score despite significant cognitive impairment. Therefore, we evaluated only patients with AD to determine the accuracy of the MMSE in distinguishing AD and cognitively healthy patients aged ≥65 years. The cutoff point was 23/24 as Folstein proposed in 1975 with a sensitivity of 92.50% and specificity of 100% [1] . The cutoff point of 24/25 was proposed by Morales et al. [28] with a sensitivity of 85% and specificity of 90% for distinguishing the same cohort. This cutoff point reached high sensitivity (95%) and specificity (94.44%) in our study as well. Additionally, higher cutoff points were proposed for screening of highly educated individuals. O'Bryant et al. [25] suggested a cutoff point of 26/27 with an optimal ratio of sensitivity (89%) and specificity (91%) and an overall correct classification rate of 90%. The same cutoff point for screening highly educated individuals of ≥65 years was optimal in our study with sensitivity of 72.73%, specificity of 96.67%, PPV of 96%, and NPV of 76.32%.
The latest MMSE guidelines proposed a cutoff point of 26/27 for screening the general population [26] . In our study, the cutoff level was the same for screening the general population irrespective of inclusion of MCI patients; however, as expected sensitivity and specificity were significantly lower when MCI cases were included. Additionally, the same cutoff point was found for screening of highly educated individuals.
To the best of our knowledge, except for a Slovenian study [24] , there are no similar studies in Croatia and surrounding Southeast European countries that share comparable cultural, educational and historic backgrounds. Our results were very similar to those of the Slovenian group [24] . Additionally, the education level of the cognitively healthy population in our study was comparable to the last population registration in Croatia (52.9% individuals who finished secondary school in our cohort compared to 47% in the Croatian population). The higher percentage of highly educated individuals in our cohort was probably due in part to the criterion of inclusion of only patients who are ≥45 years of age, and not all age groups.
In conclusion, the result of our study shows that the optimal cutoff point for screening the Croatian population overall is 26/27. For screening of a population of ≥65 years, the cutoff level is 24/25, whereas for screening of highly educated persons (≥14 years of education) aged ≥65 years, a higher cutoff point should be used (26/27) . The aim of this study is not to encourage the diagnosis of cognitive impairment based solely on the MMSE score, but rather to direct individuals at risk with a subjective or objective cognitive complaint to the dementia outpatient clinic for an additional neurocognitive and neuropsychological evaluation.
